A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors

NCT06292208 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

MTD

Interventions

BIOLOGICAL: IBD0333

Sponsor

SUNHO（China）BioPharmaceutical CO., Ltd.